138 related articles for article (PubMed ID: 7734154)
1. Separate regulation of a membrane protein, gp130, present in receptor complex specific for interleukin-6 and other functionally related cytokines.
Falus A; Biró J; Rákász E; Brunner T; Bischoff S
J Mol Recognit; 1994 Dec; 7(4):277-81. PubMed ID: 7734154
[TBL] [Abstract][Full Text] [Related]
2. Activation of the signal transducer glycoprotein 130 by both IL-6 and IL-11 requires two distinct binding epitopes.
Kurth I; Horsten U; Pflanz S; Dahmen H; Küster A; Grötzinger J; Heinrich PC; Müller-Newen G
J Immunol; 1999 Feb; 162(3):1480-7. PubMed ID: 9973404
[TBL] [Abstract][Full Text] [Related]
3. The human IL-11 receptor requires gp130 for signalling: demonstration by molecular cloning of the receptor.
Nandurkar HH; Hilton DJ; Nathan P; Willson T; Nicola N; Begley CG
Oncogene; 1996 Feb; 12(3):585-93. PubMed ID: 8637716
[TBL] [Abstract][Full Text] [Related]
4. Signal transduction through gp130 that is shared among the receptors for the interleukin 6 related cytokine subfamily.
Hirano T; Matsuda T; Nakajima K
Stem Cells; 1994 May; 12(3):262-77. PubMed ID: 8075593
[TBL] [Abstract][Full Text] [Related]
5. The soluble interleukin-6 receptor.
Rose-John S; Ehlers M; Grötzinger J; Müllberg J
Ann N Y Acad Sci; 1995 Jul; 762():207-20; discussion 220-1. PubMed ID: 7668529
[No Abstract] [Full Text] [Related]
6. FR901228, an inhibitor of histone deacetylases, increases the cellular responsiveness to IL-6 type cytokines by enhancing the expression of receptor proteins.
Blanchard F; Kinzie E; Wang Y; Duplomb L; Godard A; Held WA; Asch BB; Baumann H
Oncogene; 2002 Sep; 21(41):6264-77. PubMed ID: 12214267
[TBL] [Abstract][Full Text] [Related]
7. Regulation of bone marrow stromal cell differentiation by cytokines whose receptors share the gp130 protein.
Gimble JM; Wanker F; Wang CS; Bass H; Wu X; Kelly K; Yancopoulos GD; Hill MR
J Cell Biochem; 1994 Jan; 54(1):122-33. PubMed ID: 8126083
[TBL] [Abstract][Full Text] [Related]
8. Characterization of soluble gp130 released by melanoma cell lines: A polyvalent antagonist of cytokines from the interleukin 6 family.
Montero-Julian FA; Brailly H; Sautès C; Joyeux I; Dorval T; Mosseri V; Yasukawa K; Wijdenes J; Adler A; Gorin I; Fridman WH; Tartour E
Clin Cancer Res; 1997 Aug; 3(8):1443-51. PubMed ID: 9815830
[TBL] [Abstract][Full Text] [Related]
9. Signaling conformations of the tall cytokine receptor gp130 when in complex with IL-6 and IL-6 receptor.
Skiniotis G; Boulanger MJ; Garcia KC; Walz T
Nat Struct Mol Biol; 2005 Jun; 12(6):545-51. PubMed ID: 15895091
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-6 receptor antagonists inhibit interleukin-11 biological activity.
Sun RX; Gennaro C; Rocco S; Gu ZJ; Klein B
Eur Cytokine Netw; 1997 Mar; 8(1):51-6. PubMed ID: 9110148
[TBL] [Abstract][Full Text] [Related]
11. Specific inhibition of IL-6 signalling with monoclonal antibodies against the gp130 receptor.
Liautard J; Sun RX; Cotte N; Gaillard JP; Mani JC; Klein B; Brochier J
Cytokine; 1997 Apr; 9(4):233-41. PubMed ID: 9112331
[TBL] [Abstract][Full Text] [Related]
12. Inflammatory cytokines interleukin-6 and oncostatin m induce plasminogen activator inhibitor-1 in human adipose tissue.
Rega G; Kaun C; Weiss TW; Demyanets S; Zorn G; Kastl SP; Steiner S; Seidinger D; Kopp CW; Frey M; Roehle R; Maurer G; Huber K; Wojta J
Circulation; 2005 Apr; 111(15):1938-45. PubMed ID: 15837947
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-6-type cytokines stimulate mesenchymal progenitor differentiation toward the osteoblastic lineage.
Taguchi Y; Yamamoto M; Yamate T; Lin SC; Mocharla H; DeTogni P; Nakayama N; Boyce BF; Abe E; Manolagas SC
Proc Assoc Am Physicians; 1998; 110(6):559-74. PubMed ID: 9824538
[TBL] [Abstract][Full Text] [Related]
14. Biosynthetic and glycosylation events of the IL-6 receptor beta-subunit, gp130.
Wang Y; Fuller GM
J Cell Biochem; 1995 Apr; 57(4):610-8. PubMed ID: 7615645
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical analysis of the IL-6 family of cytokines and their receptors in benign, hyperplasic, and malignant human prostate.
Royuela M; Ricote M; Parsons MS; García-Tuñón I; Paniagua R; de Miguel MP
J Pathol; 2004 Jan; 202(1):41-9. PubMed ID: 14694520
[TBL] [Abstract][Full Text] [Related]
16. Resistance to interleukin 6 in human non-small cell lung carcinoma cell lines: role of receptor components.
Ganapathi MK; Weizer AK; Borsellino S; Bukowski RM; Ganapathi R; Rice T; Casey G; Kawamura K
Cell Growth Differ; 1996 Jul; 7(7):923-9. PubMed ID: 8809410
[TBL] [Abstract][Full Text] [Related]
17. Oncostatin M binds directly to gp130 and behaves as interleukin-6 antagonist on a cell line expressing gp130 but lacking functional oncostatin M receptors.
Sporeno E; Paonessa G; Salvati AL; Graziani R; Delmastro P; Ciliberto G; Toniatti C
J Biol Chem; 1994 Apr; 269(15):10991-5. PubMed ID: 8157624
[TBL] [Abstract][Full Text] [Related]
18. Gp130 and the interleukin-6 family of cytokines.
Taga T; Kishimoto T
Annu Rev Immunol; 1997; 15():797-819. PubMed ID: 9143707
[TBL] [Abstract][Full Text] [Related]
19. Association and activation of Btk and Tec tyrosine kinases by gp130, a signal transducer of the interleukin-6 family of cytokines.
Matsuda T; Takahashi-Tezuka M; Fukada T; Okuyama Y; Fujitani Y; Tsukada S; Mano H; Hirai H; Witte ON; Hirano T
Blood; 1995 Feb; 85(3):627-33. PubMed ID: 7530500
[TBL] [Abstract][Full Text] [Related]
20. Distinct effects of Broncho-Vaxom (OM-85 BV) on gp130 binding cytokines.
Roth M; Block LH
Thorax; 2000 Aug; 55(8):678-84. PubMed ID: 10899245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
